Cart
sales@molnova.com
Mafenide Acetate
CAS No. 13009-99-9
Mafenide Acetate( —— )
Catalog No. M21177 CAS No. 13009-99-9
Mafenide Acetate is a sulfonamide-type medication inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 30 | In Stock |
|
| 50MG | 28 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 73 | In Stock |
|
| 1G | 100 | In Stock |
|
Biological Information
-
Product NameMafenide Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMafenide Acetate is a sulfonamide-type medication inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
-
DescriptionMafenide Acetate is a sulfonamide-type medication inhibits the enzyme carbonic anhydrase and is used as topical anti-infective especially in burn therapy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
IndicationBurnsSkin Burn Requiring Skin Graft
Chemical Information
-
CAS Number13009-99-9
-
Formula Weight246.29
-
Molecular FormulaC9H14N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:35 mg/mL (142.11 mM)
-
SMILESCC(=O)O.NCc1ccc(S(N)(=O)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Haynes B.W. Jr. Mafenide acetate in burn treatment. N Engl J Med 1971. 284(23): p. 1324.
molnova catalog
related products
-
Rolapitant
Rolapitant Hydrochloride is the hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity.
-
Vanatone
It is a substrate of An arylketone monooxygenase purified from Pseudomonas putida JD1 by ion exchange and affinity chromatography.
-
Didymin
Didymin has antioxidant property. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma, may used for neuroblastoma therapy.
